216 related articles for article (PubMed ID: 22018728)
1. Lipid accumulation product (LAP) is related to androgenicity and cardiovascular risk factors in postmenopausal women.
Maturana MA; Moreira RM; Spritzer PM
Maturitas; 2011 Dec; 70(4):395-9. PubMed ID: 22018728
[TBL] [Abstract][Full Text] [Related]
2. Relation between androgens and cardiovascular risk factors in a young population.
Gannagé-Yared MH; Chedid R; Abs L
Clin Endocrinol (Oxf); 2011 Jun; 74(6):720-5. PubMed ID: 21521259
[TBL] [Abstract][Full Text] [Related]
3. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women.
Maturana MA; Breda V; Lhullier F; Spritzer PM
Metabolism; 2008 Jul; 57(7):961-5. PubMed ID: 18555838
[TBL] [Abstract][Full Text] [Related]
4. Endogenous androgen levels and cardiovascular risk profile in women across the adult life span.
Bell RJ; Davison SL; Papalia MA; McKenzie DP; Davis SR
Menopause; 2007; 14(4):630-8. PubMed ID: 17224854
[TBL] [Abstract][Full Text] [Related]
5. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease.
Joffe HV; Ridker PM; Manson JE; Cook NR; Buring JE; Rexrode KM
Ann Epidemiol; 2006 Feb; 16(2):105-12. PubMed ID: 16216530
[TBL] [Abstract][Full Text] [Related]
6. Menopausal symptoms and risk factors for cardiovascular disease in postmenopause.
Cagnacci A; Cannoletta M; Palma F; Zanin R; Xholli A; Volpe A
Climacteric; 2012 Apr; 15(2):157-62. PubMed ID: 22141325
[TBL] [Abstract][Full Text] [Related]
7. Androgens in relationship to cardiovascular risk factors in the menopausal transition.
Mesch VR; Siseles NO; Maidana PN; Boero LE; Sayegh F; Prada M; Royer M; Schreier L; Benencia HJ; Berg GA
Climacteric; 2008; 11(6):509-17. PubMed ID: 18991078
[TBL] [Abstract][Full Text] [Related]
8. The association of androgenic sex steroids with serum lipid levels in postmenopausal women.
Noyan V; Yucel A; Sagsoz N
Acta Obstet Gynecol Scand; 2004 May; 83(5):487-90. PubMed ID: 15059164
[TBL] [Abstract][Full Text] [Related]
9. SHBG levels correlate with insulin resistance in postmenopausal women.
Akin F; Bastemir M; Alkiş E; Kaptanoglu B
Eur J Intern Med; 2009 Mar; 20(2):162-7. PubMed ID: 19327605
[TBL] [Abstract][Full Text] [Related]
10. Does androgen excess contribute to the cardiovascular risk profile in postmenopausal women with type 2 diabetes?
Korytkowski MT; Krug EI; Daly MA; Deriso L; Wilson JW; Winters SJ
Metabolism; 2005 Dec; 54(12):1626-31. PubMed ID: 16311096
[TBL] [Abstract][Full Text] [Related]
11. Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women.
Worsley R; Robinson PJ; Bell RJ; Moufarege A; Davis SR
Menopause; 2013 Jun; 20(6):640-5. PubMed ID: 23531683
[TBL] [Abstract][Full Text] [Related]
12. Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study.
Agledahl I; Skjaerpe PA; Hansen JB; Svartberg J
Nutr Metab Cardiovasc Dis; 2008 May; 18(4):256-62. PubMed ID: 17560771
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
Undén AL; Elofsson S; Brismar K
Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
[TBL] [Abstract][Full Text] [Related]
14. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
[TBL] [Abstract][Full Text] [Related]
15. The lipid accumulation product is associated with increased mortality in normal weight postmenopausal women.
Wehr E; Pilz S; Boehm BO; März W; Obermayer-Pietsch B
Obesity (Silver Spring); 2011 Sep; 19(9):1873-80. PubMed ID: 21394091
[TBL] [Abstract][Full Text] [Related]
16. Testosterone, SHBG and cardiovascular health in postmenopausal women.
Brand JS; van der Schouw YT
Int J Impot Res; 2010; 22(2):91-104. PubMed ID: 20090761
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women.
El ayachi M; Mziwira M; Vincent S; Defoort C; Portugal H; Lairon D; Belahsen R
Eur J Clin Nutr; 2005 Dec; 59(12):1379-86. PubMed ID: 16118656
[TBL] [Abstract][Full Text] [Related]
18. [Study on relationship between endogenous androgens and insulin resistance at the different stages of postmenopause].
Cao YK; Zhang SF; Zou SE; Xia X; Xu LN
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):740-4. PubMed ID: 24406129
[TBL] [Abstract][Full Text] [Related]
19. The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women.
Davis SR; Robinson PJ; Moufarege A; Bell RJ
Clin Endocrinol (Oxf); 2012 Oct; 77(4):541-7. PubMed ID: 22106826
[TBL] [Abstract][Full Text] [Related]
20. Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study.
Golden SH; Ding J; Szklo M; Schmidt MI; Duncan BB; Dobs A
Am J Epidemiol; 2004 Sep; 160(6):540-8. PubMed ID: 15353414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
